CRISPR Patent Dispute Heard in Federal Court
Jim Daley | May 1, 2018
In an ongoing legal battle, the University of California, Berkeley has challenged the Broad Institute’s patent claims on the gene editing technology.
Federal Court Sides with Broad in CRISPR Patent Dispute
Federal Court Sides with Broad in CRISPR Patent Dispute
The higher court’s decision to uphold the ruling of the Patent Trial and Appeal Board essentially ends the intellectual property battle in the US.
The higher court’s decision to uphold the ruling of the Patent Trial and Appeal Board essentially ends the intellectual property battle in the US.
2017 in Quotes
Catherine Offord | Dec 28, 2017
Gender discrimination, Brexit, and climate change are among the issues that have received considerable attention from the scientific community this year.
Flux and Uncertainty in the CRISPR Patent Landscape
Aggie Mika | Oct 1, 2017
The battle for the control of the intellectual property surrounding CRISPR-Cas9 is as storied and nuanced as the technology itself.
UC Berkeley: Patent Office “Ignored Key Evidence”
Jef Akst | Jul 26, 2017
The University of California files a brief in its appeal challenging the ruling that the Broad Institute’s group would retain its CRISPR genome-editing patent.
CRISPR Oral Arguments Recap, Cont’d
Jef Akst | Dec 8, 2016
This week’s CRISPR patent hearing took a deep dive into the science of moving the gene-editing technology from prokaryotes to eukaryotic systems.
Contributors
The Scientist Staff | Oct 1, 2016
Meet some of the people featured in the October 2016 issue of The Scientist